Selective inhibition of prostacyclin synthase activity by rofecoxib.
about
Non-steroid anti-inflammatory drugs, prostaglandins, and cancer.Effects of bradykinin on venous capacitance in health and treated chronic heart failureRNAi-based strategies for cyclooxygenase-2 inhibition in cancer.Selective cyclooxygenase-2 silencing mediated by engineered E. coli and RNA interference induces anti-tumour effects in human colon cancer cells.
P2860
Selective inhibition of prostacyclin synthase activity by rofecoxib.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 2007
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Selective inhibition of prostacyclin synthase activity by rofecoxib.
@en
Selective inhibition of prostacyclin synthase activity by rofecoxib.
@nl
type
label
Selective inhibition of prostacyclin synthase activity by rofecoxib.
@en
Selective inhibition of prostacyclin synthase activity by rofecoxib.
@nl
prefLabel
Selective inhibition of prostacyclin synthase activity by rofecoxib.
@en
Selective inhibition of prostacyclin synthase activity by rofecoxib.
@nl
P2093
P2860
P50
P1476
Selective inhibition of prostacyclin synthase activity by rofecoxib.
@en
P2093
Cristiana Griffoni
Mattia Toni
Vittorio Tomasi
P2860
P304
P356
10.1111/J.1582-4934.2007.00021.X
P577
2007-03-01T00:00:00Z